M&A Deal Summary

EVERSANA Acquires Triplefin

On October 1, 2018, EVERSANA acquired business services company Triplefin from Water Street Healthcare Partners and JLL Partners

Acquisition Highlights
  • This is EVERSANA’s 1st transaction in the Business Services sector.
  • This is EVERSANA’s 3rd transaction in the United States.
  • This is EVERSANA’s 1st transaction in Ohio.

M&A Deal Summary

Date 2018-10-01
Target Triplefin
Sector Business Services
Buyer(s) EVERSANA
Sellers(s) Water Street Healthcare Partners
JLL Partners
Deal Type Merger

Target

Triplefin

Cincinnati, Ohio, United States
Triplefin LLC is a provider of integrated business process outsourcing solutions to pharmaceutical and consumer products companies. Triplefin delivers comprehensive hub services that improve patient access and adherence, including its patent-pending Rx365® suite of digital solutions. Triplefin’s programs help thousands of patients with serious diseases, offering hope and improved well-being. Its associates are dedicated to providing an empathetic, caring experience throughout a patient’s journey. The company is headquartered in Cincinnati, Ohio.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

EVERSANA

Milwaukee, Wisconsin, United States

Category Company
Sector Life Science
DESCRIPTION
EVERSANA's corporate headquarters in Milwaukee, Wisconsin.
EVERSANA's corporate headquarters in Milwaukee, Wisconsin.

EVERSANA combines global life science services into an integrated, independent and intelligent commercialization platform. With services rooted in the patient experience and spanning global pricing, market access, marketing, patient support, channel distribution, and consulting, the company creates value for patients, prescribers, and payers at all stages of the product lifecycle. EVERSANA is based in Milwaukee, Wisconsin.


DEAL STATS #
Overall 3 of 10
Sector (Business Services) 1 of 4
Type (Merger) 2 of 2
State (Ohio) 1 of 1
Country (United States) 3 of 7
Year (2018) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-01 The Access Group

Berkeley Heights, New Jersey, United States

The Access Group is a provider of marketing and advertising services to pharmaceutical, biotechnology and other health care clients. The Access Group offers pharmaceutical companies specialized expertise and capabilities that define and communicate drug therapies' value proposition to payers; educate the medical community on new drugs; and create and execute strategies that brand and market their products.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-30 Cornerstone Research Group

Burlington, Ontario, Canada

Cornerstone Research Group, Inc. is a global health economic and market access research company involved in developing evidence-based market access solutions. Cornerstone initially focused on health economics research with an emphasis on global cost-effectiveness models and Canadian reimbursement submissions. Cornerstone was formed in 2005 and is based in Burlington, Ontario.

Buy -

Seller(S) 2

SELLER

Water Street Healthcare Partners

Chicago, Illinois, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2005
PE ASSETS 6.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Water Street is a specialist private equity firm that targets investments in healthcare companies. Specific areas of interest within healthcare include diagnostic devices, medical products, pharmaceutical services, specialty distribution, specialty pharmaceuticals, and specialty services. Water Street targets non-core units of larger corporations and private middle-market companies. Transactions are typically valued between $50 and $500 million. Water Street does not invest in biotechnology, traditional healthcare facilities (hospitals, nursing homes) or early-stage companies without positive cash flow. Water Street was formed in 2005 and is based in Chicago, Illinois.


DEAL STATS #
Overall 27 of 31
Sector (Business Services) 1 of 1
Type (Merger) 4 of 4
State (Ohio) 3 of 3
Country (United States) 27 of 30
Year (2018) 5 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-01 The Access Group

Berkeley Heights, New Jersey, United States

The Access Group is a provider of marketing and advertising services to pharmaceutical, biotechnology and other health care clients. The Access Group offers pharmaceutical companies specialized expertise and capabilities that define and communicate drug therapies' value proposition to payers; educate the medical community on new drugs; and create and execute strategies that brand and market their products.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-16 Discovery Life Sciences

Huntsville, Alabama, United States

Discovery Life Sciences is a provider of biospecimen analysis, procurement, distribution, and genomic, cell-based and histology-based scientific services for the pharmaceutical, biotechnology, and diagnostics industries. HudsonAlpha Discovery is Discovery’s sequencing and bioinformatics division, a globally recognized service laboratory that leverages the most current genomic research technologies to comprehensively support discovery, translational, and clinical research. Discovery Life Sciences was founded in 2018 and is based in Huntsville, Alabama.

Buy -
SELLER

JLL Partners

New York, New York, United States

Investor Investor Investor Investor


Category Private Equity Firm
Founded 1988
PE ASSETS 5.8B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

JLL Partners, Inc. is a private equity investment firm that invests alongside management in middle-market companies. JLL prefers control investments in sectors such as healthcare services, medical products, food and consumer products, chemicals, broadcasting, transportation, automotive, industrial manufacturing, and distribution. In addition to traditional buyout transaction, JLL also seeks distressed/turnaround situations. JLL Partners was formed in 1988 and is based in New York City.


DEAL STATS #
Overall 16 of 22
Sector (Business Services) 2 of 2
Type (Merger) 2 of 4
State (Ohio) 1 of 1
Country (United States) 16 of 21
Year (2018) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-01 EVERSANA

Milwaukee, Wisconsin, United States

EVERSANA combines global life science services into an integrated, independent and intelligent commercialization platform. With services rooted in the patient experience and spanning global pricing, market access, marketing, patient support, channel distribution, and consulting, the company creates value for patients, prescribers, and payers at all stages of the product lifecycle. EVERSANA is based in Milwaukee, Wisconsin.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-28 Allucent

Cary, North Carolina, United States

Allucent is a provider of solutions that support life science organizations with advancing drug development. Allucent offers a range of services including regulatory strategy and submissions, project management, medical writing, biostatistics, data management, pharmacokinetics, pharmacovigilance, quality assurance, and trial management. Allucent was founded in 1988 and is based in Cary, North Carolina.

Buy -